Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Canadian integrative oncology research priorities: results of a consensus-building process.

Current oncology (Toronto, Ont.)·2013
Same author

Integrative oncology: a Canadian and international perspective.

Current oncology (Toronto, Ont.)·2008
Same author

How do we evaluate outcome in an integrative oncology program?

Current oncology (Toronto, Ont.)·2008
Same author

The integrative oncology supplement--a paradigm for both patient care and communication.

Current oncology (Toronto, Ont.)·2008
Same author

Chinese medicine and biomodulation in cancer patients--Part one.

Current oncology (Toronto, Ont.)·2008

Related Experiment Video

Updated: Jul 2, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Research and regulatory issues for integrative oncology.

S M Sagar1, R K W Wong

  • 1McMaster University and the Juravinski Cancer Centre, Hamilton, Ontario, Canada. stephen.sagar@jcc.hhsc.ca

Current Oncology (Toronto, Ont.)
|September 5, 2008
PubMed
Summary

Cancer patients increasingly use complementary therapies like herbs and supplements. This article reviews challenges in studying these integrative oncology approaches and implementing effective treatments.

Keywords:
Integrative oncologyacupuncturecamherbsnatural health productsregulationresearch

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Related Experiment Videos

Last Updated: Jul 2, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Area of Science:

  • Integrative oncology and complementary therapies.

Background:

  • Growing patient self-treatment with herbs, supplements, and mind-body practices.
  • Increasing involvement of practitioners like acupuncturists in cancer patient supportive care.
  • Government funding for complementary therapy research.

Purpose of the Study:

  • To provide an overview of challenges in studying complementary and alternative therapies (CATs).
  • To discuss evaluating the results of CAT studies.
  • To cover regulating the implementation of effective CATs.

Main Methods:

  • Review of current research and clinical practices in complementary oncology.
  • Discussion of methodological issues in CAT study design.
  • Analysis of evidence evaluation and regulatory considerations.

Main Results:

  • Identified significant challenges in designing rigorous studies for CATs.
  • Highlighted difficulties in interpreting and evaluating the results of such studies.
  • Discussed the complexities of regulating and implementing beneficial therapies.

Conclusions:

  • Rigorous study design is crucial for validating complementary therapies in oncology.
  • Effective evaluation and regulation are necessary for integrating useful therapies into cancer care.
  • Addressing these challenges will facilitate evidence-based use of complementary oncology treatments.